Alembic Pharmaceuticals secures final approval from FDA for hypertension drug
Alembic Pharmaceuticals Limited has successfully secured final approval from the US Food and Drug Administration (USFDA) for its Diltiazem Hydrochloride Extended-Release Capsules USP, in strengths ... Read More
Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to produce Fludrocortisone Acetate Tablets USP, 0.1 mg, according ... Read More
Zydus Lifesciences bags FDA tentative approval for Enzalutamide Tablets for prostate cancer treatment
Zydus Lifesciences Limited has secured tentative approval from the United States Food and Drug Administration (USFDA) for its Enzalutamide Tablets, available in 40 mg and ... Read More
Zydus Lifesciences launches fight against prostate cancer with new FDA-approved drug enzalutamide
Zydus Lifesciences Limited has achieved a significant milestone in the pharmaceutical industry. The company recently received final approval from the United States Food and Drug ... Read More
Upsher-Smith Laboratories launches three generic drugs in US
Upsher-Smith Laboratories has launched three new products - Fluvoxamine Maleate Tablets, Clonidine Hydrochloride Extended-Release Tablets, and Haloperidol Tablets, USP, to expand its generic portfolio. According ... Read More
Dr Reddy’s Laboratories to acquire generic injectable products in the US
Dr Reddy’s Laboratories has agreed to acquire a portfolio of 42 approved, non-marketed abbreviated new drug applications (ANDAs) in the US, which includes more than ... Read More
Teva launches generic version of Elidel Cream to expand eczema treatment options
Teva Pharmaceutical Industries has unveiled its generic version of Elidel (pimecrolimus) Cream, 1%, providing a more affordable treatment option for individuals battling mild to moderate ... Read More